Estetrol-drospirenone combination oral contraceptive: North American phase 3 efficacy and safety results-Reference-Cited by-同舟云学术

Estetrol-drospirenone combination oral contraceptive: North American phase 3 efficacy and safety results

Published:2021-09 Issue:3 Volume:104 Page:222-228
ISSN:0010-7824
Container-title:Contraception
language:en
Short-container-title:Contraception

Author:

Creinin Mitchell D.^ORCID,Westhoff Carolyn L.,Bouchard Céline^ORCID,Chen Melissa J.,Jensen Jeffrey T.,Kaunitz Andrew M.,Achilles Sharon L.^ORCID,Foidart Jean-Michel,Archer David F.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference39 articles.

1. Pharmacological profile of estrogens in oral contraception;Bitzer;Minerva Ginecol,2011

2. Epidemiology of hormonal contraceptives-related venous thromboembolism;Hugon-Rodin;Eur J Endocrinol,2014

3. Combined oral contraceptives: venous thrombosis;de Bastos;Cochrane Database Syst Rev,2014

4. Norethindrone acetate 1.0 milligram and ethinyl estradiol 10 micrograms as an ultra low-dose oral contraceptive;Archer;Obstet Gynecol,2013

5. 20 microg versus >20 microg estrogen combined oral contraceptives for contraception;Gallo;Cochrane Database Syst Rev,2013

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contraception for adolescents with medical complexities;NASPAG Essentials of Pediatric & Adolescent Gynecology;2025

2. Update on Therapies and Treatments in Women’s Health;Medical Clinics of North America;2024-09

3. Effects of E4/DRSP on self-reported physical and emotional premenstrual and menstrual symptoms: data from the phase 3 clinical trial in Europe and Russia;The European Journal of Contraception & Reproductive Health Care;2024-06-21

4. Estetrol: a new word in modern hormonal contraception. A review;Gynecology;2024-06-10

5. Estetrol/GPER/SERPINB2 transduction signaling inhibits the motility of triple-negative breast cancer cells;Journal of Translational Medicine;2024-05-13